Audrey Giocanti-Auregan
Overview
Explore the profile of Audrey Giocanti-Auregan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Viola F, Chi G, Holekamp N, Giocanti-Auregan A, Garcia-Layana A, Peto T, et al.
Ophthalmic Res
. 2024 Aug;
67(1):516-527.
PMID: 39208778
Introduction: Diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) require frequent anti-vascular endothelial growth factor (VEGF) treatment and monitoring visits. We aimed to understand the burden of treatment...
2.
Torres-Villaros H, Timoumi R, Fajnkuchen F, Klokner A, Giocanti-Auregan A
Retina
. 2024 Aug;
44(11):1937-1944.
PMID: 39208410
Purpose: To assess macular thickness fluctuations and their association with visual acuity outcomes in eyes with diabetic macular edema treated with an intravitreal dexamethasone (DEX) implant. Methods: The SD of...
3.
Holekamp N, Gentile B, Giocanti-Auregan A, Garcia-Layana A, Peto T, Viola F, et al.
Ophthalmic Res
. 2024 Apr;
67(1):311-321.
PMID: 38679018
Introduction: Understanding patient perspectives of treatment may improve adherence and outcomes. This study explored real-world patient experiences with anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema (DME) and...
4.
Dupas B, Castro-Farias D, Girmens J, Eginay A, Couturier A, Villeroy F, et al.
Trials
. 2024 Apr;
25(1):273.
PMID: 38649937
Background: Macular edema (ME) results from hyperpermeability of retinal vessels, leading to chronic extravasation of plasma components into the retina and hence potentially severe visual acuity loss. Current standard of...
5.
Enjalbert A, Giocanti-Auregan A, Fajnkuchen F, Torres-Villaros H
Retina
. 2023 Nov;
44(4):572-580.
PMID: 38029421
Purpose: To analyze the changes in macular vascular densities (VDs) and foveal avascular zone (FAZ) over a 6-year period using swept-source optical coherence tomography angiography in patients with sickle cell...
6.
Donati S, Yang C, Xu X, Mura M, Giocanti-Auregan A, Hoerauf H, et al.
Ophthalmol Ther
. 2023 Nov;
13(1):161-178.
PMID: 37924483
Introduction: AURIGA is the largest real-world study to date to evaluate intravitreal aflibercept (IVT-AFL) in the treatment of diabetic macular edema (DME) or macular edema secondary to retinal vein occlusion...
7.
Giocanti-Auregan A, Donati S, Hoerauf H, Allmeier H, Rittenhouse K, Machewitz T, et al.
Ophthalmol Ther
. 2023 Nov;
13(1):179-203.
PMID: 37924481
Introduction: AURIGA is the largest real-world study to date to evaluate intravitreal aflibercept (IVT-AFL) treatment of diabetic macular edema or macular edema secondary to retinal vein occlusion (RVO) in routine...
8.
Giocanti-Auregan A, Fajnkuchen F
Case Rep Ophthalmol
. 2023 Apr;
14(1):159-164.
PMID: 37065727
Sickle cell proliferative retinopathy usually presents first in the peripheral retina and the ability to extend and enhance our visualization of the peripheral retina would allow for superior clinical decision-making....
9.
Morel J, Fajnkuchen F, Amari F, Sritharan N, Bloch-Queyrat C, Giocanti-Auregan A
J Clin Med
. 2023 Feb;
12(4).
PMID: 36835902
: To follow the evolution of peripheral ischemia by fluorescein angiography (FA) on ultra-wide-field (UWF) images in diabetic patients treated with anti-vascular endothelial growth factor (anti-VEGF) for macular edema. :...
10.
Rohart C, Le H, Estrada-Walker J, Giocanti-Auregan A, Cohen S
Retina
. 2023 Feb;
43(6):882-887.
PMID: 36727798
Purpose: To report the very long-term visual prognosis of choroidal neovascularization complicating angioid streaks in the antivascular endothelial growth factor era. Methods: Retrospective monocentric study aimed at analyzing patients' demographics,...